Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Ebumab Holding ApS
APS
Active
CVR 39807556
Ole Maaløes Vej 3, 2200
København N
Activities of head offices
·
NACE 7010
Est. 2018 · 7 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Activities of head offices
/
Ebumab Holding ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
EBITDA
DKK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Revenue
-87
-16
0
0
0
Staff expenses
-0
-300
-1
-0
-1
EBITDA
-87
-316
-22
-57
-46
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-87
-316
-22
-57
-46
Net financials
75.756
266
242
185
157
Profit before tax
75.670
-50
220
129
111
Tax
35
-11
48
29
-53
Net profit
75.635
-39
171
100
163
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
5.769
5.684
5.745
5.579
6.541
Equity
5.684
5.605
5.644
5.473
5.373
Long-term debt
0
0
0
0
1.133
Short-term debt
85
78
101
106
35
Total debt
85
78
101
106
1.168
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2021
2025
Equity ratio
98,5 %
This company
38,2 %
Market median
This company
Market median
158% above market
2021
2025
Return on equity
>999 %
This company
18,4 %
Market median
This company
Market median
>999% above market
2021
2025
Net profit margin
>999 %
This company
8,1 %
Market median
This company
Market median
>999% above market
2021
2025
Asset turnover
-0,02×
This company
1,12×
Market median
This company
Market median
102% below market
2021
2025
Debt / equity
0,01×
This company
0,62×
Market median
This company
Market median
98% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Ebumab Holding ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
